Stem Cell Therapy Market by Type (Allogeneic, Autologous), Therapeutic Application (Musculoskeletal, Wound & Injury, CVD, Autoimmune & Inflammatory), Cell Source (Adipose tissue, Bone Marrow, Placenta/Umbilical Cord) - Global Forecasts to 2026", published by MarketsandMarkets™, the global market is projected to reach USD 401 million by 2026 from USD 187 million in 2021, at a CAGR of 16.5% during the forecast period.
Browse and
in-depth TOC on "Stem Cell Therapy
Market"
142 - Tables
45 - Figures
160 - Pages
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48
The
Market growth is driven mainly by factors such as increasing investment in stem
cell research and the rising number of GMP-certified stem cell manufacturing
plants. However, factors such as ethical concerns and the high cost of stem
cell research and manufacturing process likely to hinder the growth of this
market.
The adipose tissue-derived MSCs segment accounted for
the largest share of the cell source segment in the Stem Cell Therapy Market in
2020.
Based on
the cell source from which stem cells are obtained, the global market is
segmented into four sources. These include adipose tissue-derived MSCs
(mesenchymal stem cells), bone marrow-derived MSCs, placenta/umbilical
cord-derived MSCs, and other cell sources (which includes human corneal
epithelium stem cells, peripheral arterial-derived stem cells, and induced
pluripotent stem cell lines). In 2020, adipose tissue-derived MSCs accounted
for the markets largest share due to their increasing utilization in treating
inflammatory diseases and wounds & injuries. There are several associated
advantages, such as ease of harvesting stem cells by minimally invasive
methods, simplicity of the isolation procedure, and better quality &
proliferation capacity of adipose tissue-derived stem cells.
The musculoskeletal disorders segment accounted for
the largest share of the therapeutic application segment in the Stem Cell
Therapy Market in 2020
Based on
therapeutic application, the global market is segmented into musculoskeletal
disorders, wounds & injuries, cardiovascular diseases, surgeries,
inflammatory & autoimmune diseases, neurological disorders, and other
therapeutic applications (which include ocular diseases, fat loss, and
peripheral arterial diseases). In 2020, the musculoskeletal disorders segment
accounted for the largest share of the therapeutic application segment. The
large market share of this segment is attributed to the increasing prevalence
of musculoskeletal disorders such as osteoarthritis, bone repair, and
regeneration
Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=48
The Asia Pacific region
is the fastest-growing region of the Stem Cell Therapy Market in 2020.
The Asia Pacific region
is estimated to grow at the highest CAGR in the market during the forecast
period. Some of the major factors fueling the growth of the APAC market include
regulatory approvals and guidelines for product approvals and the presence of
major stem cell players in countries such as South Korea, Japan, India, and Australia.
Key
players in the Stem Cell Therapy Market include Smith & Nephew (UK),
MEDIPOST Co., Ltd. (South
Korea), Anterogen Co., Ltd. (South Korea), PHARMICELL Co., Ltd.
(South Korea),
JCR Pharmaceuticals Co., Ltd. (Japan),
and NuVasive, Inc. (US).
Speak to Analyst: -https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=48
About MarketsandMarkets™
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies'
revenues. Currently servicing 7500 customers worldwide including 80% of global
Fortune 1000 companies as clients. Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our 850
fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth
markets following the "Growth Engagement Model – GEM". The GEM aims
at proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators, strategic
players) annually in high growth emerging segments. MarketsandMarkets™ is
determined to benefit more than 10,000 companies this year for their revenue
planning and help them take their innovations/disruptions early to the market
by providing them research ahead of the curve.
MarketsandMarkets's
flagship competitive intelligence and market research platform,
"Knowledgestore" connects over 200,000 markets and entire value
chains for deeper understanding of the unmet insights along with market sizing and
forecasts of niche markets.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™
INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA:
1-888-600-6441
Email: sales@marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/stem-cells-market.asp
ResearchInsight: -https://www.marketsandmarkets.com/ResearchInsight/stem-cell-technologies-and-global-market.asp
No comments:
Post a Comment